Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Sarepta Therapeutics - 28 Year Stock Price History | SRPT

Historical daily share price chart and data for Sarepta Therapeutics since 1997 adjusted for splits and dividends. The latest closing stock price for Sarepta Therapeutics as of June 20, 2025 is 20.08.
  • The all-time high Sarepta Therapeutics stock closing price was 178.74 on December 22, 2020.
  • The Sarepta Therapeutics 52-week high stock price is 164.52, which is 719.3% above the current share price.
  • The Sarepta Therapeutics 52-week low stock price is 18.30, which is 8.9% below the current share price.
  • The average Sarepta Therapeutics stock price for the last 52 weeks is 105.55.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Sarepta Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 76.3318 124.0900 127.8900 20.0800 20.0800 -83.49%
2024 128.0012 96.2100 163.8500 93.7000 121.5900 26.09%
2023 116.7710 124.8400 157.1900 67.3100 96.4300 -25.58%
2022 91.8743 90.4200 132.1300 62.6900 129.5800 43.90%
2021 82.5635 165.2900 168.9500 65.9700 90.0500 -47.18%
2020 137.8229 129.0900 178.7400 82.3800 170.4900 32.12%
2019 117.1305 107.5000 156.9100 72.8100 129.0400 18.24%
2018 105.9535 58.2500 161.5100 54.0200 109.1300 96.14%
2017 39.1454 27.9200 56.7500 27.6700 55.6400 102.84%
2016 26.6847 38.0700 62.3500 10.7400 27.4300 -28.90%
2015 25.1902 14.9400 41.7900 11.6100 38.5800 166.62%
2014 24.1064 20.5800 38.9100 12.6000 14.4700 -28.96%
2013 33.2875 26.2400 53.8100 12.8900 20.3700 -21.05%
2012 11.8641 4.4400 44.9300 3.4600 25.8000 477.18%
2011 8.6942 13.0200 15.4800 3.2400 4.4700 -64.86%
2010 10.0156 9.4800 13.0800 6.9000 12.7200 45.21%
2009 8.0033 4.0800 14.8200 3.3006 8.7600 121.88%
2008 7.1255 8.5200 11.2800 2.8800 3.9480 -53.33%
2007 16.1696 18.5400 19.2000 7.8600 8.4600 -55.66%
2006 28.7693 20.3400 51.9000 15.4800 19.0800 -7.83%
2005 15.9895 13.5000 24.8400 12.0000 20.7000 46.81%
2004 16.0193 24.4800 28.5000 9.5400 14.1000 -42.26%
2003 29.0970 29.2200 42.3000 12.2400 24.4200 -18.60%
2002 37.5321 66.2400 77.8200 16.1940 30.0000 -54.21%
2001 44.1415 25.8750 67.1400 18.0000 65.5188 129.89%
2000 61.9312 34.5000 157.1250 24.3750 28.5000 -12.64%
1999 23.7946 24.3750 43.5000 15.3750 32.6250 35.94%
1998 32.6403 40.8750 45.9375 16.5000 24.0000 -41.28%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.973B $1.902B
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company that focuses on the discovery and development of RNA-based therapeutics targeting rare and infectious diseases. It concentrates on the development of exon-skipping drug candidates targeting Duchenne muscular dystrophy (DMD), a rare genetic disorder affecting children. The company received accelerated approval for Exondys 51, Amondys 45 (casimersen) and Vyondys 53 (golodirsen). Exondys 51 is Sarepta's first PMO-based technology to be granted accelerated approval by the FDA. The company is conducting a confirmatory study on the clinical benefits of these drugs for gaining continued approval. The rest of its exon-skipping DMD pipeline includes a PPMO-based, exon 51 skipping candidate, SRP-5051. Sarepta is also developing gene therapies for treating DMD, Limb-girdle muscular dystrophy and central nervous system disorders including Mucopolysaccharidosis type IIIA and Pompe Disease.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $216.937B 16.19
Amgen (AMGN) United States $155.575B 13.94
Gilead Sciences (GILD) United States $134.966B 14.02
Vertex Pharmaceuticals (VRTX) United States $113.214B 0.00
Bristol Myers Squibb (BMY) United States $95.364B 6.38
GSK (GSK) United Kingdom $77.943B 9.33
CSL (CSLLY) Australia $75.392B 0.00
Regeneron Pharmaceuticals (REGN) United States $55.032B 13.36
Alnylam Pharmaceuticals (ALNY) United States $40.381B 0.00
Argenex SE (ARGX) Netherlands $33.103B 90.36
BioNTech SE (BNTX) Germany $25.609B 0.00
Royalty Pharma (RPRX) United States $19.600B 8.28
Insmed (INSM) United States $19.480B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $18.796B 0.00
Biogen (BIIB) United States $18.615B 8.03
Illumina (ILMN) United States $14.325B 27.17
Genmab (GNMSF) Denmark $13.948B 14.26
Genmab (GMAB) Denmark $13.568B 15.22
Incyte (INCY) United States $13.252B 100.68
Exelixis (EXEL) United States $11.009B 18.69
Ascendis Pharma (ASND) Denmark $10.814B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.548B 17.13
QIAGEN (QGEN) Netherlands $10.394B 20.23
Moderna (MRNA) United States $10.017B 0.00
Exact Sciences (EXAS) United States $10.002B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $9.633B 24.60
Blueprint Medicines (BPMC) United States $8.279B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.030B 0.00
Bio-Techne Corp (TECH) United States $7.821B 29.17
Roivant Sciences (ROIV) United Kingdom $7.784B 0.00
Revolution Medicines (RVMD) United States $7.387B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Repligen (RGEN) United States $6.677B 74.75
Halozyme Therapeutics (HALO) United States $6.507B 12.45
Jazz Pharmaceuticals (JAZZ) Ireland $6.506B 6.39
Legend Biotech (LEGN) United States $6.248B 0.00
Guardant Health (GH) United States $6.088B 0.00
Telix Pharmaceuticals (TLX) Australia $5.801B 0.00
TG Therapeutics (TGTX) United States $5.718B 150.08
Nuvalent (NUVL) United States $5.386B 0.00
Axsome Therapeutics (AXSM) United States $4.958B 0.00
Alkermes (ALKS) Ireland $4.797B 12.87
Akero Therapeutics (AKRO) United States $4.321B 0.00
Vaxcyte (PCVX) United States $4.240B 0.00
ADMA Biologics Inc (ADMA) United States $4.235B 31.68
Zealand Pharma (ZLDPF) Denmark $4.201B 0.00
PTC Therapeutics (PTCT) United States $3.979B 6.92
Rhythm Pharmaceuticals (RYTM) United States $3.944B 0.00
Cytokinetics (CYTK) United States $3.873B 0.00
Krystal Biotech (KRYS) United States $3.828B 29.50
CRISPR Therapeutics AG (CRSP) Switzerland $3.822B 0.00
Zai Lab (ZLAB) China $3.812B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.801B 33.40
Merus (MRUS) Netherlands $3.676B 0.00
SpringWorks Therapeutics (SWTX) United States $3.538B 0.00
Avidity Biosciences (RNA) United States $3.532B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.511B 0.00
Arcellx (ACLX) United States $3.472B 0.00
Protagonist Therapeutics (PTGX) United States $3.306B 71.12
Ascentage Pharma Group - (AAPG) China $3.257B 0.00
Scholar Rock Holding (SRRK) United States $3.232B 0.00
Metsera (MTSR) United States $3.110B 0.00
Kymera Therapeutics (KYMR) United States $2.987B 0.00
Viking Therapeutics (VKTX) United States $2.921B 0.00
Alvotech (ALVO) Luxembourg $2.819B 16.12
MoonLake Immunotherapeutics (MLTX) Switzerland $2.785B 0.00
Immunovant (IMVT) United States $2.701B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.587B 0.00
ImmunityBio (IBRX) United States $2.533B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.494B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.459B 0.00
Anbio Biotechnology (NNNN) Germany $2.317B 0.00
Apellis Pharmaceuticals (APLS) United States $2.223B 0.00
Ligand Pharmaceuticals (LGND) United States $2.201B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.116B 0.00
Vericel (VCEL) United States $2.115B 1400.67
Bavarian Nordic (BVNRY) Denmark $2.111B 11.15
Twist Bioscience (TWST) United States $2.076B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.075B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.045B 0.00
Denali Therapeutics (DNLI) United States $2.018B 0.00
Agios Pharmaceuticals (AGIO) United States $1.993B 0.00
CG Oncology (CGON) United States $1.948B 0.00
Apogee Therapeutics (APGE) United States $1.932B 0.00
Belite Bio (BLTE) United States $1.926B 0.00
IDEAYA Biosciences (IDYA) United States $1.898B 0.00
NovoCure (NVCR) Jersey $1.861B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.831B 12.17
Disc Medicine (IRON) United States $1.787B 0.00
Amicus Therapeutics (FOLD) United States $1.737B 188.00
Certara (CERT) United States $1.710B 31.94
Tarsus Pharmaceuticals (TARS) United States $1.708B 0.00
Beam Therapeutics (BEAM) United States $1.685B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.647B 0.00
GRAIL (GRAL) United States $1.641B 0.00
Adaptive Biotechnologies (ADPT) United States $1.577B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.574B 0.00
Edgewise Therapeutics (EWTX) United States $1.504B 0.00
Biohaven (BHVN) United States $1.477B 0.00
89BIO (ETNB) United States $1.472B 0.00
ANI Pharmaceuticals (ANIP) United States $1.420B 14.63
Janux Therapeutics (JANX) United States $1.397B 0.00
Celldex Therapeutics (CLDX) United States $1.361B 0.00
Mesoblast (MESO) Australia $1.333B 0.00
Vera Therapeutics (VERA) United States $1.330B 0.00
Travere Therapeutics (TVTX) United States $1.271B 0.00
BGM Group (BGM) China $1.271B 0.00
Structure Therapeutics (GPCR) United States $1.246B 0.00
CureVac (CVAC) Germany $1.220B 5.91
Viridian Therapeutics (VRDN) United States $1.201B 0.00
Dynavax Technologies (DVAX) United States $1.200B 71.36
MannKind (MNKD) United States $1.146B 23.56
Liquidia Technologies (LQDA) United States $1.126B 0.00
Pacira BioSciences (PCRX) United States $1.122B 10.67
Niagen Bioscience (NAGE) United States $1.059B 149.33
Novavax (NVAX) United States $1.038B 2.42
AbCellera Biologics (ABCL) Canada $1.018B 0.00
WAVE Life Sciences (WVE) Singapore $1.013B 0.00
Geron (GERN) United States $0.962B 0.00
Intellia Therapeutics (NTLA) United States $0.953B 0.00
Pharvaris (PHVS) Netherlands $0.941B 0.00
CorMedix Inc (CRMD) United States $0.923B 61.86
Arcus Biosciences (RCUS) United States $0.913B 0.00
Spyre Therapeutics (SYRE) United States $0.905B 0.00
NeoGenomics (NEO) United States $0.901B 0.00
Mineralys Therapeutics (MLYS) United States $0.879B 0.00
Nurix Therapeutics (NRIX) United States $0.876B 0.00
Zymeworks (ZYME) United States $0.868B 0.00
ArriVent BioPharma (AVBP) United States $0.863B 0.00
Praxis Precision Medicines (PRAX) United States $0.862B 0.00
MiMedx (MDXG) United States $0.858B 20.75
LENZ Therapeutics (LENZ) United States $0.843B 0.00
Oculis Holding AG (OCS) Switzerland $0.842B 0.00
Cogent Biosciences (COGT) United States $0.823B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.816B 0.00
Oric Pharmaceuticals (ORIC) United States $0.793B 0.00
UniQure (QURE) Netherlands $0.778B 0.00
Anavex Life Sciences (AVXL) United States $0.776B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Immunome (IMNM) United States $0.761B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Gyre Therapeutics (GYRE) United States $0.757B 201.75
Phathom Pharmaceuticals (PHAT) United States $0.727B 0.00
Vir Biotechnology (VIR) United States $0.723B 0.00
Replimune (REPL) United States $0.715B 0.00
Pharming Group (PHAR) Netherlands $0.711B 0.00
Trevi Therapeutics (TRVI) United States $0.699B 0.00
Immatics (IMTX) Germany $0.682B 0.00
AnaptysBio (ANAB) United States $0.681B 0.00
Urogen Pharma (URGN) United States $0.675B 0.00
Nuvation Bio (NUVB) United States $0.670B 0.00
Iovance Biotherapeutics (IOVA) United States $0.661B 0.00
Arbutus Biopharma (ABUS) United States $0.657B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.641B 0.00
GH Research (GHRS) Ireland $0.640B 0.00
Sionna Therapeutics (SION) United States $0.639B 0.00
Stoke Therapeutics (STOK) United States $0.632B 14.66
Sana Biotechnology (SANA) United States $0.588B 0.00
Upstream Bio (UPB) United States $0.585B 0.00
Sage Therapeutics (SAGE) United States $0.582B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.579B 0.00
Tango Therapeutics (TNGX) United States $0.559B 0.00
Keros Therapeutics (KROS) United States $0.548B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.546B 0.00
Arvinas (ARVN) United States $0.543B 0.00
Dianthus Therapeutics (DNTH) United States $0.542B 0.00
Castle Biosciences (CSTL) United States $0.535B 36.31
Mind Medicine (MindMed) (MNMD) United States $0.533B 0.00
Opthea (OPT) Australia $0.525B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.514B 0.00
MeiraGTx Holdings (MGTX) United States $0.510B 0.00
Bicara Therapeutics (BCAX) United States $0.508B 0.00
Kura Oncology (KURA) United States $0.506B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.502B 0.00
Tyra Biosciences (TYRA) United States $0.490B 0.00
Maze Therapeutics (MAZE) United States $0.490B 0.00
Fortrea Holdings (FTRE) United States $0.481B 13.30
Septerna (SEPN) United States $0.467B 0.00
ATyr Pharma (ATYR) United States $0.465B 0.00
Myriad Genetics (MYGN) United States $0.454B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.453B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.453B 0.00
Cullinan Therapeutics (CGEM) United States $0.453B 0.00
Celcuity (CELC) United States $0.439B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.439B 0.00
Precigen (PGEN) United States $0.428B 0.00
REGENXBIO (RGNX) United States $0.423B 0.00
PureTech Health (PRTC) United States $0.419B 0.00
Kamada (KMDA) Israel $0.414B 24.83
Rapport Therapeutics (RAPP) United States $0.399B 0.00
Erasca (ERAS) United States $0.388B 0.00
Zenas BioPharma (ZBIO) United States $0.384B 0.00
Benitec Biopharma (BNTC) United States $0.384B 0.00
ITeos Therapeutics (ITOS) United States $0.381B 0.00
Abivax SA (ABVX) France $0.379B 0.00
Northwest Biotherapeutics (NWBO) United States $0.378B 0.00
Fulcrum Therapeutics (FULC) United States $0.378B 0.00
Cytek Biosciences (CTKB) United States $0.374B 0.00
Solid Biosciences (SLDB) United States $0.371B 0.00
Tectonic Therapeutic (TECX) United States $0.370B 0.00
Vigil Neuroscience (VIGL) United States $0.370B 0.00
Eton Pharmaceuticals (ETON) United States $0.364B 0.00
Humacyte (HUMA) United States $0.358B 0.00
Absci (ABSI) United States $0.356B 0.00
Rezolute (RZLT) United States $0.351B 0.00
Terns Pharmaceuticals (TERN) United States $0.341B 0.00
Emergent Biosolutions (EBS) United States $0.338B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.333B 0.00
Compass Therapeutics (CMPX) United States $0.332B 0.00
Astria Therapeutics (ATXS) United States $0.331B 0.00
Gossamer Bio (GOSS) United States $0.327B 0.00
MBX Biosciences (MBX) United States $0.326B 0.00
Inventiva S.A (IVA) France $0.315B 0.00
Ocugen (OCGN) United States $0.310B 0.00
Prothena (PRTA) Ireland $0.308B 0.00
Aura Biosciences (AURA) United States $0.304B 0.00
Abeona Therapeutics (ABEO) United States $0.301B 0.00
Alpha Teknova (TKNO) United States $0.297B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.288B 0.00
XOMA Royalty (XOMA) United States $0.288B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.285B 57.88
Olema Pharmaceuticals (OLMA) United States $0.283B 0.00
Atea Pharmaceuticals (AVIR) United States $0.278B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.275B 0.00
Prime Medicine (PRME) United States $0.272B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.271B 0.00
Verastem (VSTM) United States $0.271B 0.00
Entrada Therapeutics (TRDA) United States $0.270B 8.79
Corvus Pharmaceuticals (CRVS) United States $0.270B 0.00
Allogene Therapeutics (ALLO) United States $0.269B 0.00
Sagimet Biosciences (SGMT) United States $0.267B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.266B 0.00
Cidara Therapeutics (CDTX) United States $0.264B 0.00
Foghorn Therapeutics (FHTX) United States $0.263B 0.00
Annexon (ANNX) United States $0.261B 0.00
Amarin (AMRN) Ireland $0.260B 0.00
Inozyme Pharma (INZY) United States $0.258B 0.00
DBV Technologies S.A (DBVT) France $0.257B 0.00
Lifecore Biomedical (LFCR) United States $0.257B 0.00
Cartesian Therapeutics (RNAC) United States $0.253B 0.00
Neurogene (NGNE) United States $0.253B 0.00
Third Harmonic Bio (THRD) United States $0.246B 0.00
Palvella Therapeutics (PVLA) United States $0.244B 0.00
Aardvark Therapeutics (AARD) United States $0.241B 0.00
Tvardi Therapeutics (TVRD) United States $0.241B 0.00
Candel Therapeutics (CADL) United States $0.238B 0.00
Prima BioMed (IMMP) Australia $0.234B 0.00
BioStem Technologies (BSEM) $0.230B 9.35
Semper Paratus Acquisition (TVGN) United States $0.221B 0.00
MaxCyte (MXCT) United States $0.217B 0.00
Inhibrx Biosciences (INBX) United States $0.216B 0.13
Adherex Technologies (FENC) United States $0.214B 0.00
Adocia (ADOCY) France $0.213B 0.00
Design Therapeutics (DSGN) United States $0.212B 0.00
Cardiff Oncology (CRDF) United States $0.206B 0.00
I-Mab (IMAB) United States $0.204B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.203B 0.00
ScPharmaceuticals (SCPH) United States $0.203B 0.00
Monopar Therapeutics (MNPR) United States $0.201B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.200B 0.00
CARGO Therapeutics (CRGX) United States $0.197B 0.00
GENFIT S.A (GNFT) France $0.196B 0.00
Bright Minds Biosciences (DRUG) United States $0.192B 0.00
Kodiak Sciences (KOD) United States $0.191B 0.00
Codexis (CDXS) United States $0.190B 0.00
AC Immune (ACIU) Switzerland $0.189B 0.00
Citius Oncology (CTOR) United States $0.188B 0.00
CytomX Therapeutics (CTMX) United States $0.187B 4.83
Editas Medicine (EDIT) United States $0.186B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.182B 0.00
Instil Bio (TIL) United States $0.182B 0.00
Nuvectis Pharma (NVCT) United States $0.170B 0.00
Spero Therapeutics (SPRO) United States $0.169B 0.00
Innate Pharma S.A (IPHA) France $0.166B 0.00
Voyager Therapeutics (VYGR) United States $0.164B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.163B 0.00
EnGene Holdings (ENGN) Canada $0.161B 0.00
Ventyx Biosciences (VTYX) United States $0.161B 0.00
Puma Biotechnology (PBYI) United States $0.159B 4.15
Molecular Partners AG (MOLN) Switzerland $0.157B 0.00
Alumis (ALMS) United States $0.156B 0.00
BioAge Labs (BIOA) United States $0.156B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.155B 0.00
DiaMedica Therapeutics (DMAC) United States $0.155B 0.00
Galena Biopharma (SLS) United States $0.154B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.153B 0.00
Anika Therapeutics (ANIK) United States $0.152B 0.00
Alector (ALEC) United States $0.147B 0.00
Alpha Cognition (ACOG) Canada $0.147B 0.00
INmune Bio (INMB) United States $0.147B 0.00
Actuate Therapeutics (ACTU) United States $0.147B 0.00
Compugen (CGEN) Israel $0.146B 0.00
Fate Therapeutics (FATE) United States $0.136B 0.00
Kyverna Therapeutics (KYTX) United States $0.133B 0.00
Black Diamond Therapeutics (BDTX) United States $0.132B 38.83
Agenus (AGEN) United States $0.131B 0.00
Elicio Therapeutics (ELTX) United States $0.129B 0.00
BeyondSpring (BYSI) United States $0.128B 0.00
Neumora Therapeutics (NMRA) United States $0.127B 0.00
Nkarta (NKTX) United States $0.126B 0.00
Caribou Biosciences (CRBU) United States $0.125B 0.00
Contineum Therapeutics (CTNM) United States $0.123B 0.00
Rapt Therapeutics (RAPT) United States $0.123B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.120B 0.00
Greenwich LifeSciences (GLSI) United States $0.119B 0.00
Seer (SEER) United States $0.118B 0.00
23andMe Holding (MEHCQ) United States $0.117B 0.00
Theratechnologies (THTX) Canada $0.116B 0.00
BioHarvest Sciences (BHST) Canada $0.116B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.115B 0.00
Genelux (GNLX) United States $0.112B 0.00
TuHURA Biosciences (HURA) United States $0.111B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.109B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.109B 0.00
Sangamo Therapeutics (SGMO) United States $0.107B 0.00
Quantum Biopharma (QNTM) Canada $0.102B 0.00
C4 Therapeutics (CCCC) United States $0.101B 0.00
Whitehawk Therapeutics (WHWK) United States $0.098B 0.00
Forte Biosciences (FBRX) United States $0.097B 0.00
Tenaya Therapeutics (TNYA) United States $0.096B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.094B 0.00
HilleVax (HLVX) United States $0.093B 0.00
Immuneering (IMRX) United States $0.092B 0.00
Coya Therapeutics (COYA) United States $0.092B 0.00
Cabaletta Bio (CABA) United States $0.091B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.090B 0.00
Nautilus Biotechnology (NAUT) United States $0.090B 0.00
Entera Bio (ENTX) Israel $0.090B 0.00
Adagene (ADAG) China $0.090B 0.00
Invivyd (IVVD) United States $0.089B 0.00
Coherus Oncology (CHRS) United States $0.087B 0.00
IO Biotech (IOBT) Denmark $0.086B 0.00
Climb Bio (CLYM) United States $0.082B 0.00
Cellectis S.A (CLLS) France $0.082B 0.00
TScan Therapeutics (TCRX) United States $0.081B 0.00
OKYO Pharma (OKYO) $0.080B 0.00
Pliant Therapeutics (PLRX) United States $0.079B 0.00
Jasper Therapeutics (JSPR) United States $0.077B 0.00
Zura Bio (ZURA) United States $0.077B 0.00
EXoZymes (EXOZ) United States $0.077B 0.00
XBiotech (XBIT) United States $0.076B 0.00
Elutia (ELUT) United States $0.074B 0.00
PDS Biotechnology (PDSB) United States $0.074B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.073B 0.00
Inovio Pharmaceuticals (INO) United States $0.072B 0.00
IGM Biosciences (IGMS) United States $0.070B 0.00
Immunic (IMUX) United States $0.069B 0.00
Biomea Fusion (BMEA) United States $0.068B 0.00
Sutro Biopharma (STRO) United States $0.068B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.067B 0.00
Skye Bioscience (SKYE) United States $0.067B 0.00
Ikena Oncology (IKNA) United States $0.066B 0.00
TELA Bio (TELA) United States $0.065B 0.00
Clearside Biomedical (CLSD) United States $0.065B 0.00
Oncolytics Biotech (ONCY) Canada $0.065B 0.00
Seres Therapeutics (MCRB) United States $0.065B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.063B 0.00
MediciNova (MNOV) United States $0.063B 0.00
Akoya Biosciences (AKYA) United States $0.063B 0.00
Immix Biopharma (IMMX) United States $0.062B 0.00
Alto Neuroscience (ANRO) United States $0.061B 0.00
Repare Therapeutics (RPTX) Canada $0.060B 0.00
CervoMed (CRVO) United States $0.060B 0.00
Quince Therapeutics (QNCX) United States $0.059B 0.00
Renovaro (RENB) United States $0.059B 0.00
VistaGen Therapeutics (VTGN) United States $0.058B 0.00
Connect Biopharma Holdings (CNTB) United States $0.057B 0.00
Oncobiologics (OTLK) United States $0.057B 0.00
Opus Genetics (IRD) United States $0.057B 0.00
Genenta Science S.p.A (GNTA) Italy $0.056B 0.00
Senti Biosciences (SNTI) United States $0.056B 0.00
Adicet Bio (ACET) United States $0.055B 0.00
Adlai Nortye (ANL) Cayman Islands $0.054B 0.00
ZIVO Bioscience (ZIVO) United States $0.054B 0.00
Kronos Bio (KRON) United States $0.054B 0.00
Werewolf Therapeutics (HOWL) United States $0.053B 0.00
InflaRx (IFRX) Germany $0.053B 0.00
Precision BioSciences (DTIL) United States $0.053B 0.00
Cue Biopharma (CUE) United States $0.053B 0.00
Fortress Biotech (FBIO) United States $0.053B 0.00
Annovis Bio (ANVS) United States $0.051B 0.00
RenovoRx (RNXT) United States $0.050B 0.00
VTv Therapeutics (VTVT) United States $0.050B 0.00
Applied Therapeutics (APLT) United States $0.049B 0.00
PepGen (PEPG) United States $0.047B 0.00
Atara Biotherapeutics (ATRA) United States $0.047B 0.00
Exicure (XCUR) United States $0.047B 0.00
Adverum Biotechnologies (ADVM) United States $0.047B 0.00
Aligos Therapeutics (ALGS) United States $0.046B 0.00
Shattuck Labs (STTK) United States $0.046B 0.00
Mersana Therapeutics (MRSN) United States $0.046B 0.00
Kalaris Therapeutics (KLRS) United States $0.045B 0.00
Celularity (CELU) United States $0.042B 0.00
Artiva Biotherapeutics (ARTV) United States $0.038B 0.00
Clene (CLNN) United States $0.038B 0.00
Alterity Therapeutics - (ATHE) Australia $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
Estrella Immunopharma (ESLA) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Radiopharm Theranostics - (RADX) Australia $0.036B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
Lantern Pharma (LTRN) United States $0.034B 0.00
Scilex Holding (SCLX) United States $0.034B 0.00
Rein Therapeutics (RNTX) United States $0.034B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.034B 0.00
Medicus Pharma (MDCX) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.032B 0.00
OnKure Therapeutics (OKUR) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
ABVC BioPharma (ABVC) United States $0.031B 0.00
Pluri (PLUR) Israel $0.031B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
Vor Biopharma (VOR) $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Rani Therapeutics Holdings (RANI) United States $0.029B 0.00
CAMP4 Therapeutics (CAMP) United States $0.028B 0.00
Dyadic (DYAI) United States $0.027B 0.00
FibroBiologics (FBLG) United States $0.027B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.027B 0.00
KALA BIO (KALA) United States $0.026B 0.00
ALX Oncology Holdings (ALXO) United States $0.026B 0.00
Generation Bio (GBIO) United States $0.025B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
Passage Bio (PASG) United States $0.024B 0.00
Cadrenal Therapeutics (CVKD) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
BioAtla (BCAB) United States $0.023B 0.00
Boundless Bio (BOLD) United States $0.023B 0.00
CalciMedica (CALC) United States $0.023B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
Curis (CRIS) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Ovid Therapeutics (OVID) United States $0.022B 0.00
Femasys (FEMY) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.021B 0.00
BRIACELL THERAP (BCTX) Canada $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Beyond Air (XAIR) United States $0.020B 0.00
Q32 Bio (QTTB) United States $0.019B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.019B 0.00
Aytu BioPharma (AYTU) United States $0.018B 0.00
Longeveron (LGVN) United States $0.018B 0.00
Imunon (IMNN) United States $0.018B 0.00
Cingulate (CING) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.016B 0.00
Cognition Therapeutics (CGTX) United States $0.016B 0.00
HOOKIPA Pharma (HOOK) United States $0.016B 0.00
Leap Therapeutics (LPTX) United States $0.016B 0.00
X4 Pharmaceuticals (XFOR) United States $0.015B 0.00
Gelteq (GELS) Australia $0.015B 0.00
Advanced Biomed (ADVB) Taiwan $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.014B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
Allarity Therapeutics (ALLR) United States $0.014B 0.00
UNITY Biotechnology (UBX) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
MetaVia (MTVA) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Rallybio (RLYB) United States $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
Eyenovia (EYEN) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Athira Pharma (ATHA) United States $0.012B 0.00
Equillium (EQ) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
BioXcel Therapeutics (BTAI) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Novogen (KZIA) Australia $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.009B 0.00
Jade Biosciences (JBIO) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.008B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.008B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Intensity Therapeutics (INTS) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
HCW Biologics (HCWB) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Synaptogenix (SNPX) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Mainz Biomed (MYNZ) Germany $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Moleculin Biotech (MBRX) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00